The task force determines which preventive services insurers must cover at no cost to patients.

Health Secretary Robert F Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer ...

LONDON -- The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...

LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

The Trump administration is considering a dramatic cutback and eventual phasing out of the President’s Emergency Plan for ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

HIV funding cuts. 820 words. 2 photos available. PHOENIX – Ending the spread of HIV in Arizona may become more difficult if ...

Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...

Adults with perinatally acquired HIV and those with HIV acquired via other routes had similar rates of AIDS-defining conditions during the transition to adult care.

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...